NASDAQ · Analyst Forecast

CNS Pharmaceuticals, Inc. (CNSP) Stock Forecast & Price Target

$4.15 NASDAQ: CNSP Market Cap $6.07M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering CNS Pharmaceuticals, Inc. (CNSP), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For CNS Pharmaceuticals, Inc., analysts forecast revenue rising from $23.20M in 2025 to $77.32M in 2030; the average estimate for 2030 earnings per share is $2.28; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$4.15
Consensus targetThe average of the price targets analysts have published.$0.50
Median targetThe middle target, less affected by a single outlier.$0.50
Highest targetThe most optimistic published target.$0.50
Lowest targetThe most pessimistic published target.$0.50
Difference from priceHow far the consensus target sits from today’s price.-88.0%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$23.20M$23.20M$23.20M1
2026$40.76M$40.76M$40.76M1
2027$50.00M$50.00M$50.00M1
2028$76.19M$76.19M$76.19M1
2029$0$0$01
2030$77.32M$77.32M$77.32M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$27.43−$27.43−$27.431
2026−$1.65−$1.65−$1.651
2027−$1.66−$1.66−$1.661
2028−$1.88−$1.88−$1.881
2029−$1.99−$1.99−$1.991
2030$2.28$2.28$2.281

CNS Pharmaceuticals, Inc. (CNSP) forecast — frequently asked questions

What is the analyst price target for CNS Pharmaceuticals, Inc.?

Analysts covering CNS Pharmaceuticals, Inc. (CNSP) have a consensus price target of $0.50, 88.0% below the current price of $4.15. Published targets range from $0.50 to $0.50. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for CNS Pharmaceuticals, Inc.'s earnings?

The average analyst estimate for CNS Pharmaceuticals, Inc. (CNSP) earnings per share in 2030 is 2.28, with individual estimates between 2.28 and 2.28.

How much revenue is CNS Pharmaceuticals, Inc. expected to make?

Analysts forecast CNS Pharmaceuticals, Inc. (CNSP) revenue of $77.32M in 2030, based on 1 published estimates.

How many analysts cover CNSP?

1 analyst contribute estimates for CNS Pharmaceuticals, Inc. (CNSP). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.